课题基金 / 基金详情

Analysis of mechanisms by which malignant pleural mesothelioma grows and invades: application to pathological diagnosis and development of a new therapy

Analysis of mechanisms by which malignant pleural mesothelioma grows and invades: application to pathological diagnosis and development of a new therapy
恶性胸膜间皮瘤生长和侵袭机制分析:在病理诊断中的应用及新疗法的开发
批准号:
23590438
负责人:
TSUJIMURA Tohru
金额:
$3.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

TSUJIMURA Tohru的其他基金

相似基金

相关文献

中文摘要
翻译
恶性间皮瘤以胸腔弥漫性生长和胸壁侵袭性增殖为特征,预后不良。为了阐明恶性间皮瘤发展这些特征的机制,我们比较了恶性间皮瘤和间皮细胞之间的基因表达谱。我们发现EZH2在恶性间皮瘤中的表达水平高于间皮细胞,EZH2有助于表观遗传沉默靶基因。当EZH2-siRNA的导入抑制间皮瘤细胞中EZH2的表达时,这些细胞的增殖能力下降。恶性间皮瘤手术标本中EZH2表达的免疫组织化学分析显示,EZH2的高表达与患者总生存期缩短有关。表观遗传学似乎参与了恶性间皮瘤的生物学特性,如胸腔内的生长和胸壁的侵袭。
英文摘要
Malignant mesothelioma is characterized by diffuse growth in the thoracic cavity and invasive proliferation in the chest wall, leading to poor prognosis. To clarify the mechanism by which malignant mesothelioma develops these features, we compared the gene expression profiling between malignant mesothelioma and mesothelial cells. We found that EZH2, which contributes to epigenetic silencing of target genes, was expressed at higher levels in malignant mesothelioma than in mesothelial cells. When EZH2 expression in mesothelioma cells was suppressed by the introduction of EZH2-siRNA, proliferation of these cells decreased. Immunohistochemical analysis of EZH2 expression in surgical specimens of malignant mesothelioma revealed correlation between higher expression of EZH2 and shorter overall survival of patients. It seems that epigenetics participates in biological characteristics of malignant mesothelioma, such as the growth in the thoracic cavity and the invasion into the chest wall.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circulating tumor cell (CTC) as a significant clinical marker in epithelioid-type malignant pleural mesothelioma (MPM)
循环肿瘤细胞(CTC)作为上皮样型恶性胸膜间皮瘤(MPM)的重要临床标志物
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Yoneda K, Sato A, Tsujimura T et al(全15名)]
通讯作者: Tsujimura T et al(全15名)
Circulating endothelial cell (CEC), a surrogate of tumor angiogenesis, as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM)
循环内皮细胞 (CEC) 是肿瘤血管生成的替代物,可作为恶性胸膜间皮瘤 (MPM) 的诊断和预后标志物
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Yoneda K, Sato A, Tsujimura T et al(全15名)]
通讯作者: Tsujimura T et al(全15名)
DOI: 10.1084/jem.20111653
发表时间: 2012-03-12
期刊: The Journal of experimental medicine
影响因子: --
作者: [Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, Hida T, Tsujimura T, Osada H, Sekido Y]
通讯作者: Sekido Y
肉腫型悪性胸膜中皮腫の細胞学的検討
肉瘤型恶性胸膜间皮瘤的细胞学研究
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [鳥居良貴, 石田誠実, 辻村亨, 他(全9名)]
通讯作者: 他(全9名)
共 19 条
    Development of early diagnosis of malignant mesothelioma : Comprehensive analysis of secretory and membrane proteins
    • 批准号:
      20590377
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      TSUJIMURA Tohru
    • 依托单位:
    Study on the differentiation of oval cells for the development of liver-targeted regenerative medicine
    • 批准号:
      17590363
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      TSUJIMURA Tohru
    • 依托单位:
    Regenerative medicine for liver diseases : Analysis of the development and differentiation of hepatic oval cells
    • 批准号:
      15590356
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2003
    • 负责人:
      TSUJIMURA Tohru
    • 依托单位:
    Analysis of liver regeneration : A study using c-kit mutants
    • 批准号:
      13670232
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      TSUJIMURA Tohru
    • 依托单位:
    海外基金